Reduced intensity allogeneic hematopoietic stem cell transplantion for MDS using tacrolimus/sirolimus-based GVHD prophylaxis

We report a consecutive series of 59 patients with MDS who underwent reduced-intensity hematopoietic stem cell transplantation (RI-HSCT) with fludarabine/melphalan conditioning and tacrolimus/sirolimus-based GVHD prophylaxis. Two-year OS, EFS, and relapse incidences were 75.1%, 65.2%, and 20.9%, res...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Nakamura, Ryotaro, Palmer, Joycelynne M., O'Donnell, Margaret R., Stiller, Tracey, Thomas, Sandra H., Chao, Joseph, Alvarnas, Joseph, Parker, Pablo M., Pullarkat, Vinod, Maegawa, Rodrigo, Stein, Anthony S., Snyder, David S., Bhatia, Ravi, Chang, Karen, Wang, Shirong, Cai, Ji-Lian, Senitzer, David, Forman, Stephen J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3433241/
https://ncbi.nlm.nih.gov/pubmed/22677229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2012.04.022
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller